Journal Information

Statistics

Follow this link to access the full text of the article

Carta ‐ Caso clínico
Reação fototóxica induzida por vandetanibe evoluindo para necrólise epidérmica tóxica
Busra Demirbag Gula,
Corresponding author
busrademirbag@windowslive.com

Autor para correspondência.
, Nilgun Senturka, Deniz Baycelebib, Levent Yildizb
a Departamento de Dermatologia, Ondokuz Mayıs University, Faculdade de Medicina, Samsun, Turquia
b Departamento de Patologia, Ondokuz Mayıs University, Faculdade de Medicina, Samsun, Turquia
Read
3541
Times
was read the article
1451
Total PDF
2090
Total HTML
Share statistics
Article information
ISSN: 26662752
Original language: Portuguese
The statistics are updated each day
Year/Month Html Pdf Total
2024 March 166 71 237
2024 February 141 78 219
2024 January 119 50 169
2023 December 94 66 160
2023 November 84 63 147
2023 October 69 75 144
2023 September 71 69 140
2023 August 53 20 73
2023 July 80 30 110
2023 June 72 34 106
2023 May 60 26 86
2023 April 62 19 81
2023 March 92 48 140
2023 February 51 34 85
2023 January 52 43 95
2022 December 51 38 89
2022 November 73 47 120
2022 October 123 62 185
2022 September 72 63 135
2022 August 60 52 112
2022 July 42 52 94
2022 June 64 57 121
2022 May 57 49 106
2022 April 75 72 147
2022 March 51 63 114
2022 February 77 50 127
2022 January 50 90 140
2021 December 29 30 59
Show all

Follow this link to access the full text of the article

Idiomas
Anais Brasileiros de Dermatologia
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.